Use of fullerenols in the preparation of a tumor prevention or treatment drug for inducing training immunity
CN122124099APending Publication Date: 2026-06-02INST OF HIGH ENERGY PHYSICS CHINESE ACAD OF SCI
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- INST OF HIGH ENERGY PHYSICS CHINESE ACAD OF SCI
- Filing Date
- 2026-02-02
- Publication Date
- 2026-06-02
Smart Images

Figure CN122124099A_ABST
Abstract
The present application relates to the technical field of biological medicine, and particularly relates to application of fullerenol in preparation of tumor prevention or treatment drugs for inducing trained immunity. The present application finds that fullerenol can induce formation of trained immunity, activate immune reprogramming of bone marrow hematopoietic stem cells, produce long-term pro-inflammatory phenotype, form persistent immune memory, and further enhance functions of innate immune cells. It is verified by experiments that fullerenol can significantly inhibit tumor growth in an animal model without obvious systemic toxicity; epigenetic remodeling of bone marrow hematopoietic stem cells can be sustained for several weeks to several months, and has long-acting anti-recurrence potential. In addition, trained immunity induced by fullerenol can be used for immune regulation of various solid tumors, and fullerenol is simple in synthesis, can be produced on a large scale, has excellent biocompatibility and stability. Therefore, the present application has wide application prospect.
Need to check novelty before this filing date? Find Prior Art